HomepageCRL • NYSE
add
Charles River Laboratories
$Â 138,79
Na sluitingstijd:(0,00%)0,00
$Â 138,79
Gesloten: 9 mei, 18:22:52 GMT-4 · USD · NYSE · Disclaimer
Vorige slotkoers
$Â 141,36
Dag-range
$Â 138,46 - $Â 143,46
Jaar-range
$Â 91,86 - $Â 254,15
Beurswaarde
6,82Â mld. USD
Gem. volume
2,26Â mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 984,17Â mln. | -2,71% |
Bedrijfskosten | 206,08Â mln. | -1,77% |
Netto inkomsten | 25,47Â mln. | -62,17% |
Netto winstmarge | 2,59 | -61,11% |
Winst per aandeel | 2,34 | 3,08% |
EBITDA | 218,88Â mln. | -4,14% |
Effectief belastingtarief | 28,07% | — |
Balans
Totale activa
Totale passiva
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 229,36Â mln. | -29,87% |
Totale activa | 7,58Â mld. | -7,00% |
Totale passiva | 4,34Â mld. | -2,43% |
Totaal aandelenvermogen | 3,24 mld. | — |
Uitstaande aandelen | 49,12 mln. | — |
Koers-boekwaardeverhouding | 2,17 | — |
Rendement op activa | 4,43% | — |
Rendement op kapitaal | 5,35% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 25,47Â mln. | -62,17% |
Operationele kasstroom | 171,70Â mln. | 32,19% |
Kasstroom uit beleggingen | -45,48Â mln. | 46,99% |
Kasstroom uit financiering | -105,32Â mln. | -674,10% |
Nettomutatie in liquide middelen | 26,16Â mln. | -51,61% |
Vrije kasstroom | 147,04Â mln. | 279,41% |
Over
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists, who condemn the company's use of dogs and non-human primates for pharmaceutical research. The company is also a major harvester of blood from horseshoe crabs. Wikipedia
Opgericht
1947
Hoofdvestiging
Website
Werknemers
19.400